Medicare Enrolled
Dr. Lorren Mott, M.D.
Interventional Cardiology · Weatherford, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mott from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mott?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mott
Dr. Lorren Mott is an interventional cardiology specialist in Weatherford, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mott performed 6,436 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mott received a total of $6,750 from 40 pharmaceutical and/or device companies across 368 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mott is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in TX
$6,750 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,436
Medicare services
Top 8% in TX for interventional cardiology
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,144 | $88 | $218 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
925 | $60 | $154 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
538 | $118 | $279 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
512 | $10 | $26 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
474 | $4 | $10 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
471 | $40 | $58 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
457 | $59 | $135 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
213 | $11 | $25 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
193 | $16 | $39 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
193 | $21 | $60 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
172 | $333 | $755 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
171 | $53 | $135 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
169 | $97 | $221 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
140 | $108 | $284 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
95 | $84 | $202 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
88 | $134 | $295 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
52 | $21 | $48 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
52 | $7 | $16 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
48 | $127 | $306 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
44 | $174 | $399 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
44 | $54 | $141 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
43 | $20 | $46 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
39 | $42 | $103 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
37 | $83 | $408 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
29 | $61 | $191 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
26 | $39 | $84 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
21 | $84 | $183 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
20 | $44 | $99 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
15 | $8 | $21 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
11 | $144 | $349 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.2% high complexity
25.3% medium
65.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,750
Total received (2018-2024)
Avg $964/year across 7 years
Bottom 42% in TX for interventional cardiology
40
Companies
368
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$728
2023
$985
2022
$1,192
2021
$897
2020
$637
2019
$977
2018
$1,335
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$197
Merck Sharp & Dohme LLC
$68
PFIZER INC.
$65
Inari Medical, Inc.
$59
Janssen Pharmaceuticals, Inc
$38
Inspire Medical Systems, Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Kiniksa Pharmaceuticals International, plc
$25
Alnylam Pharmaceuticals Inc.
$24
Abbott Laboratories
$23
AstraZeneca Pharmaceuticals LP
$21
Novo Nordisk Inc
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Lexicon Pharmaceuticals, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$18
CVRx, Inc.
$16
SCPHARMACEUTICALS INC.
$15
E.R. Squibb & Sons, L.L.C.
$14
Recor Medical Inc
$13
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,344
Amgen Inc.
$594
E.R. Squibb & Sons, L.L.C.
$559
Acutus Medical, Inc.
$505
HeartFlow, Inc.
$455
PFIZER INC.
$427
Janssen Pharmaceuticals, Inc
$315
Amarin Pharma Inc.
$251
SANOFI-AVENTIS U.S. LLC
$239
Abbott Laboratories
$232
AstraZeneca Pharmaceuticals LP
$215
Merck Sharp & Dohme LLC
$207
Boehringer Ingelheim Pharmaceuticals, Inc.
$191
Regeneron Healthcare Solutions, Inc.
$173
Penumbra, Inc.
$149
Allergan Inc.
$116
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$88
Merck Sharp & Dohme Corporation
$77
Actelion Pharmaceuticals US, Inc.
$75
Inari Medical, Inc.
$59
Lundbeck LLC
$40
Inspire Medical Systems, Inc.
$38
Kiniksa Pharmaceuticals, Ltd.
$37
Novo Nordisk Inc
$32
SCPHARMACEUTICALS INC.
$31
Boston Scientific Corporation
$30
United Therapeutics Corporation
$28
Gilead Sciences, Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$28
Kiniksa Pharmaceuticals International, plc
$25
Alnylam Pharmaceuticals Inc.
$24
Astellas Pharma US Inc
$19
Kowa Pharmaceuticals America, Inc.
$18
Lexicon Pharmaceuticals, Inc.
$18
CVRx, Inc.
$16
ATRICURE, INC.
$15
Esperion Therapeutics, Inc.
$14
Cardiovascular Systems Inc.
$13
Recor Medical Inc
$13
Otsuka America Pharmaceutical, Inc.
$11
Top 3 companies account for 37.0% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · Arcalyst · BRILINTA · BYSTOLIC · BYVALSON · Barostim Neo System · CAMZYOS · CARDIOMEMS · Confirm Rx · Corlanor · ELIQUIS · ENSITE · ENTRESTO · Ellipse ICD · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · Fortify Assura · GIVLAARI · INSPIRE · Indigo · JARDIANCE · LEQVIO · LEXISCAN · LINZESS · LifeVest · Livalo · MULTAQ · NEXLETOL · NORTHERA · ORENITRAM · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · Repatha · S · SAMSCA · SYNERGY ABLATION SYSTEM · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · UPTRAVI · VERQUVO · VIIBRYD · VYNDAQEL · Vascepa · WATCHMAN · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Interventional cardiologists in nearby ZIP areas
1
County median income
$102,099
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY WEATHERFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mott is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mott experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mott performed 1,144 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mott receive payments from pharmaceutical companies?
Yes. Dr. Mott received a total of $6,750 from 40 companies across 368 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mott's costs compare to other interventional cardiologists in Weatherford?
Dr. Mott's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mott) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Weatherford
Browse interventional cardiologists in Weatherford ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in TX
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in TX
Which TX interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology